fbpx

Galaxy Diagnostics

Go Beyond the Limits of Detection

Provider Portal
Blog

Bartonella Testing

by on

Three Important Considerations for Bartonella IFA Serology Testing

Immunofluorescence assay (IFA) is an established serology test method used in both research and clinical settings to confirm exposure to a pathogen. Although it is a useful tool for supporting diagnosis of many infectious diseases, choosing the appropriate testing and interpreting results for a suspected chronic bartonellosis case is often more complex than the average [...]

by on

Neuroretinitis Caused by Bartonellosis – Always a fever?

The classic description of cat scratch disease (acute Bartonella henselae infection) includes fever and lymphadenopathy (swollen lymph nodes). Additionally, an estimated 5-10% of patients develop eye-related manifestations of bartonellosis with or without the classic symptoms. In one study of patients with neuroretinitis (inflammation of the optic nerve and retina) caused by bartonellosis, as many as [...]

by on

Now Offering Antibody Tests for Bartonella vinsonii berkhoffii and Bartonella koehlerae!

Earlier this week, we announced that IFA serology (IgG) testing is now available at Galaxy Diagnostics for two additional Bartonella species: B. vinsonii berkhoffii and B. koehlerae. Access to reliable testing for a broader range of Bartonella species will improve the clinical outcomes of high-risk patient populations, such as veterinarians and other people who regularly [...]

by on

Watch Galaxy’s Director of Research and Development Answer FAQs from Patients and Providers

Jennifer Miller, PhD is the director of research and development as well as the assistant lab director at Galaxy Diagnostics. Dr. Miller holds a doctorate in microbiology and brings an exceptional and diverse background in microbiology research and education, including over 20 years of experience with vector-borne pathogens. She recently sat down with us to [...]

by on

Bartonella and Co-Infections Presentations from the 5th Annual LymeMIND Virtual Conference

The 5th annual LymeMIND Virtual Conference held in October 2020 is available online. A session on “Bartonella and Co-infections” featured several speakers, including two Galaxy Diagnostics scientists. The speakers focused on what we know now about Bartonella species infection in people and hypotheses to drive future research. These hypotheses all require more advanced molecular and [...]

by on

Galaxy Diagnostics’ President and CEO Reflects on Diagnostics Commercialization and Novel Alzheimer’s Disease Biotechnology Development

Amanda Elam, PhD, President and CEO of Galaxy Diagnostics, recently spoke at the 2021 Intracell Research Group Conference, Before Amyloid Beta: Exploring Pre-pathology Events in Alzheimer’s Disease. Videos of all of the presentations can be found here and here. Dr. Elam’s presentation can be found 53 minutes into the second video. In this presentation, Dr. [...]

Sign Up to Receive Blog Updates!